Omega Life Science
Medical Devices for Aerosol Drug Delivery
Company Overview
Snapshot
Founded in January 2011, Omega Life Science operates with 1–10 employees. The company has developed a proprietary inhaler platform, Alphazer, which produces aerosols for drug delivery.
Business overview
Omega Life Science specializes in developing medical devices for aerosol drug delivery, focusing on systemic, local, and CNS targeting. The company's core technology includes a proprietary inhaler platform, Alphazer, and tailor-made formulation technology. This platform generates submicron- to micron-sized droplets and submicron- to nano-sized dry particles of pharmaceutical compounds. Omega Life Science serves the healthcare and life sciences industries, particularly targeting pharmaceuticals, patients, and providers with its inhalation and drug delivery solutions.
Log in to access full profile ›Company Intelligence Q&A
- What is Omega Life Science's primary focus?
- Omega Life Science focuses on developing medical devices for aerosol drug delivery, targeting systemic, local, and central nervous system applications.
- What is the Alphazer platform?
- The Alphazer is Omega Life Science's proprietary inhaler platform designed to produce submicron- to micron-sized droplets and submicron- to nano-sized dry particles of pharmaceutical compounds for drug delivery.
- When was Omega Life Science founded?
- Omega Life Science was founded in January 2011.
- What markets does Omega Life Science serve?
- Omega Life Science serves global markets within the healthcare and life sciences sectors, including pharmaceuticals, patients, and providers.
- What is the company's employee count?
- Omega Life Science has 1–10 employees.